These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


144 related items for PubMed ID: 6268270

  • 1. A study of immunoreactive calcitonin (CT), adrenocorticotropic hormone (ACTH) and carcinoembryonic antigen (CEA) in lung cancer and other malignancies.
    Krauss S, Macy S, Ichiki AT.
    Cancer; 1981 May 15; 47(10):2485-92. PubMed ID: 6268270
    [Abstract] [Full Text] [Related]

  • 2. [Radioimmunologic evaluation of the prognosis and effective therapy of patients with small cell lung cancer].
    Ausekar BP6, Smirnova KD, Gromova NV, Perevodchikova NI.
    Med Radiol (Mosk); 1985 Nov 15; 30(11):18-20. PubMed ID: 2999553
    [Abstract] [Full Text] [Related]

  • 3. A preliminary evaluation of calcitonin and PDN-21 as tumor markers for lung cancer. EORTC Lung Cancer Working Party.
    Body JJ, Dumon JC, Sculier JP, Dabouis G, Lacroix H, Libert P, Richez M, Bureau G, Mommen P, Raymakers N.
    Henry Ford Hosp Med J; 1989 Nov 15; 37(3-4):190-3. PubMed ID: 2639133
    [Abstract] [Full Text] [Related]

  • 4. Tumor markers in patients with lung cancer.
    Hansen M, Pedersen AG.
    Chest; 1986 Apr 15; 89(4 Suppl):219S-224S. PubMed ID: 3007040
    [Abstract] [Full Text] [Related]

  • 5. Circulating arginine-vasopressin, calcitonin, carcinoembryonic antigen, neuron-specific enolase, and beta-2 microglobulin fluctuations during combined modality induction therapy for small-cell bronchogenic carcinoma. Association of postchemotherapy AVP surge with high tumor response rate and durable remission.
    Biran H, Feld R, Malkin A.
    Tumour Biol; 1991 Apr 15; 12(3):131-7. PubMed ID: 1648782
    [Abstract] [Full Text] [Related]

  • 6. Serum NSE, CEA, CT, CA 15-3 levels in human lung cancer.
    Nutini S, Cappelli G, Benucci A, Catalani C, Nozzoli F.
    Int J Biol Markers; 1990 Apr 15; 5(4):198-202. PubMed ID: 1965544
    [Abstract] [Full Text] [Related]

  • 7. Infrequent elevation of plasma ACTH in patients with bronchogenic carcinoma.
    Davis S, May PB.
    Am J Med Sci; 1982 Apr 15; 283(1):2-7. PubMed ID: 6275702
    [Abstract] [Full Text] [Related]

  • 8. Ectopic hormones in lung cancer patients at diagnosis and during therapy.
    Gropp C, Havemann K, Scheuer A.
    Cancer; 1980 Jul 15; 46(2):347-54. PubMed ID: 6248192
    [Abstract] [Full Text] [Related]

  • 9. Multiple sequential biomarkers in monitoring patients with carcinoma of the lung.
    Aroney RS, Dermody WC, Aldenderfer P, Parsons P, McNitt K, Marangos PJ, Whitacre MY, Ruddon RW, Wiernik PH, Aisner J.
    Cancer Treat Rep; 1984 Jun 15; 68(6):859-66. PubMed ID: 6329508
    [Abstract] [Full Text] [Related]

  • 10. Carcinoembronic antigen and endocrine response in a patient with Sipple's syndrome following surgery.
    Nakada T, Shigematsu H, Nagayama T, Miyauchi T, Yoshida Y, Sakiyama S, Katayama T, Shimada F.
    Endocrinol Jpn; 1981 Oct 15; 28(5):551-62. PubMed ID: 6284492
    [Abstract] [Full Text] [Related]

  • 11. Ectopic production of big ACTH in carcinoma of the lung. Its clinical usefulness as a biologic marker.
    Ayvazian LF, Schneider B, Gewirtz G, Yalow RS.
    Am Rev Respir Dis; 1975 Mar 15; 111(3):279-87. PubMed ID: 164143
    [Abstract] [Full Text] [Related]

  • 12. [Biochemical methods and their place in prognosis and evaluation of the effectiveness of treatment of small cell lung cancer].
    Bassalyk LS, Tkacheva GA, Ausekar BV, Smirnova KD, Gershteĭn ES.
    Vopr Onkol; 1985 Mar 15; 31(10):28-32. PubMed ID: 2998083
    [Abstract] [Full Text] [Related]

  • 13. The values of calcitonin and carcinoembryonic antigen in the treatment and management of nonfamilial medullary thyroid carcinoma.
    Rougier P, Calmettes C, Laplanche A, Travagli JP, Lefevre M, Parmentier C, Milhaud G, Tubiana M.
    Cancer; 1983 Mar 01; 51(5):855-62. PubMed ID: 6821852
    [Abstract] [Full Text] [Related]

  • 14. [The importance of measuring plasma carcinoembryonic antigen in small-cell anaplastic carcinoma].
    Michetti G, Bamberga M, Pugliese C, Ori Belometti M, Arnone P, Minio A, Ciaravino G, Villa R, Alesina R, Cottini M.
    Minerva Med; 1994 May 01; 85(5):231-6. PubMed ID: 8028751
    [Abstract] [Full Text] [Related]

  • 15. ACTH, ADH, and calcitonin concentrations as markers of response and relapse in small-cell carcinoma of the lung.
    Hansen M, Hammer M, Hummer L.
    Cancer; 1980 Nov 01; 46(9):2062-7. PubMed ID: 6253049
    [Abstract] [Full Text] [Related]

  • 16. Production of immunoreactive corticotropin-releasing hormone in various neuroendocrine tumors.
    Tsuchihashi T, Yamaguchi K, Abe K, Yanaihara N, Saito S.
    Jpn J Clin Oncol; 1992 Aug 01; 22(4):232-7. PubMed ID: 1359172
    [Abstract] [Full Text] [Related]

  • 17. Five tumor markers in lung cancer: significance of total and "lipid"-bound sialic acid.
    Kakari S, Stringou E, Toumbis M, Ferderigos AS, Poulaki E, Chondros K, Dema A, Kotsovoulou V, Pavlidis N.
    Anticancer Res; 1991 Aug 01; 11(6):2107-10. PubMed ID: 1663720
    [Abstract] [Full Text] [Related]

  • 18. [Tumor markers in C-cell cancer].
    Raue F, Schmidt-Gayk H, Ziegler R.
    Dtsch Med Wochenschr; 1983 Feb 25; 108(8):283-7. PubMed ID: 6297868
    [Abstract] [Full Text] [Related]

  • 19. Ectopic ACTH production in carcinoma of the lung.
    Gewirtz G, Yalow RS.
    J Clin Invest; 1974 Apr 25; 53(4):1022-32. PubMed ID: 4360854
    [Abstract] [Full Text] [Related]

  • 20. Plasma calcitonin as a marker of disease activity in patients with small cell carcinoma of the lung.
    Wallach SR, Royston I, Taetle R, Wohl H, Deftos LJ.
    J Clin Endocrinol Metab; 1981 Sep 25; 53(3):602-6. PubMed ID: 6267098
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.